BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹172 Cr | ₹157 Cr | ₹193 Cr | ₹233 Cr | ₹204 Cr |
What is the latest Total Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹193 Cr |
| Mar2022 | ₹233 Cr |
| Mar2021 | ₹204 Cr |
How is Total Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹172 Cr | 9.09 | |
| Mar2024 | ₹157 Cr | -18.55 | |
| Mar2023 | ₹193 Cr | -17.09 | |
| Mar2022 | ₹233 Cr | 14.46 | |
| Mar2021 | ₹204 Cr | - | |
Compare Total Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,830.9 Cr | 11.1% | -0.5% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 11.1% |
-0.5% |
-17.6% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses